Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Reconstitute at 0.2 mg/mL in sterile PBS.
MCV Type II refers to the Merkel cell polyomavirus (MCV or MCPyV) type II, which is one of the most significant risk factors for Merkel cell carcinoma (MCC), a rare but aggressive form of skin cancer. MCV is a member of the polyomavirus family and is commonly found in the skin of healthy individuals, where it usually remains asymptomatic. However, in certain circumstances, such as immunosuppression or UV exposure, MCV can integrate into the host genome and become oncogenic. The integration typically disrupts the viral genome, leading to the expression of viral oncoproteins, such as the large T antigen and small T antigen, which interfere with cell cycle regulation and promote uncontrolled cell proliferation. MCV Type II is one of the variants of this virus, characterized by specific genetic sequences that may influence its pathogenicity and the host's immune response. Understanding the molecular biology of MCV Type II, including its mechanisms of integration and oncogenesis, is crucial for developing diagnostic, preventive, and therapeutic strategies for MCC. Research into MCV Type II also provides broader insights into viral-induced carcinogenesis and the potential for targeting viral components in cancer treatment.
仅用于科研。不用于诊断过程。未经明确授权不得转售。